: refers to a collection of risk factors for type 2 diabetes and heart disease that includes abdominal obesity (belly fat), high blood pressure, elevated blood sugar, low HDL (“good”) cholesterol, and high triglycerides (another type of blood fat).The metabolic syndrome is a cluster of the most dangerous heart attack risk factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. A quarter of the world’s adults have metabolic syndrome and the condition increases in frequency with age. People with metabolic syndrome are twice as likely to die from, and three times as likely to have a heart attack or stroke compared with people without the syndrome.
Nonalcoholic fatty liver disease (NAFLD):
refers to a wide spectrum of liver diseases ranging from the most common, fatty liver (accumulation of fat in the liver, also known as steatosis, to nonalcoholic steatohepatitis to cirrhosis. All of the stages on nonalcoholic fatty liver disease are now believed to be due to insulin resistance, a condition associated with obesity.
Many studies conducted on patients suffering from metabolic syndrome, confirms a significant reduction of cholesterol, glucose, and triglycerides by taking BPF.Furthermore, bergamot fruit has other mechanisms of action that contribute to its lipid-lowering effects, such as reducing triglyceride accumulation in the liver and increasing the binding of cholesterol to bile acids and their excretion in the intestinal tract.
Rapresentative CT scans from patients suffering from metabolic syndrome
showing the effect of BPF® given orally for 120 consecutive days before
meals (650mg x 2 daily) on liver steatosis.